Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Jiahui Health Highlights China’s Growing Role in Global Medical Tourism at WTO Public Forum 2026

    September 18, 2026

    Bayer to Present How it Rebuilt Global Planning with OMP at Gartner Supply Chain Planning Summit 2026

    September 17, 2026

    Nepal flood missing count rises to 6,150 after verification

    September 17, 2026
    Facebook X (Twitter) Instagram
    Tel Aviv ReporterTel Aviv Reporter
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • More
      • Sports
      • Technology
      • Travel
    Tel Aviv ReporterTel Aviv Reporter
    Home » Cellebrite Files its 2025 Annual Report on Form 20-F
    PR Newswire

    Cellebrite Files its 2025 Annual Report on Form 20-F

    March 4, 2026
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 4, 2026 /PRNewswire/ — Cellebrite (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that the Company has filed its Annual Report on Form 20-F for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the “SEC”).

    Cellebrite Logo

    Cellebrite’s 2025 Annual Report on Form 20-F is available on the investor relations section of its website at https://investors.cellebrite.com/financial-information/sec-filings and on the SEC’s website at www.sec.gov. Shareholders may request a hard copy of the 2025 Annual Report on Form 20-F, free of charge, by contacting the Company at investors@cellebrite.com.

    References to Websites and Social Media Platforms
    References to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference of the information contained at or available through such websites or social media platforms, and you should not consider such information to be part of this press release.

    About Cellebrite
    Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate more than 1.5 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com.

    Investor Relations
    Andrew Kramer
    Vice President, Investor Relations
    investors@cellebrite.com
    +1 973.206.7760

    Media
    Victor Cooper
    Sr. Director of Corporate Communications + Content Operations
    Victor.cooper@cellebrite.com
    +1 404.804.5910

    Logo – https://mma.prnewswire.com/media/2855183/Cellebrite_Logo.jpg

    Cision View original content:https://www.prnewswire.co.uk/news-releases/cellebrite-files-its-2025-annual-report-on-form-20-f-302703283.html

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Jiahui Health Highlights China’s Growing Role in Global Medical Tourism at WTO Public Forum 2026

    September 18, 2026

    Cellebrite Expands Global Digital Community, ‘The 101’, for Digital Forensics and Investigative Professionals

    September 17, 2026

    CGX&OCR Brings Chinese Innovation to the Global Obstacle Racing Stage

    September 17, 2026

    Lutris Pharma to Present Updated Data from Its Phase 2 Trial of LUT014 Gel for the Treatment of Patients With EGFRI-Induced Acneiform Rash at the EADV Congress

    September 16, 2026

    Nitinotes Announces First EASE™ Clinical Trial Procedures at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Italy

    September 15, 2026

    Cellebrite CTO Chris Wade to Lead Cellebrite Labs, Sharpening Focus on Mobile Research

    September 14, 2026
    Latest News

    Nepal flood missing count rises to 6,150 after verification

    September 17, 2026

    WHO reports Ebola progress as DR Congo outbreak continues

    September 17, 2026

    Gold prices decline on Federal Reserve rate decision in trading

    September 17, 2026

    NYC finds Legionella DNA in Yankee Stadium cooling tower

    September 16, 2026

    Hainan evacuates over 55,000 after extreme rainfall

    September 16, 2026

    Apple adds first foldable iPhone to lineup with iPhone Duo

    September 16, 2026

    Fleet expands as Emirates enters winter season with strong bookings

    September 15, 2026
    © 2026 Tel Aviv Reporter | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.